» Articles » PMID: 9291182

Hypoxia Stimulates Proximal Tubular Cell Matrix Production Via a TGF-beta1-independent Mechanism

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1997 Sep 18
PMID 9291182
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Tubulointerstitial fibrosis is characterized by tubular basement membrane thickening and accumulation of interstitial extracellular matrix (ECM). Since chronic low-grade hypoxia has been implicated in the pathogenesis of fibrosis and proximal tubular epithelial cells (PTE) are sensitive to oxygen deprivation, we hypothesized that hypoxia may stimulate ECM accumulation. In human PTE, hypoxia (1% O2, 24 hr) increased total collagen production (15%), decreased MMP-2 activity (55% +/- 13%; control = 100%) and increased tissue inhibitor of metalloproteinase-1 (TIMP-1) protein. Collagen IV mRNA levels decreased while collagen I mRNA increased, suggesting induction of interstitial collagen. Hypoxia-induced changes persisted on re-oxygenation with increased expression of TIMP mRNAs. A potential mediator for these effects is transforming growth factor-beta1 (TGF-beta1), a major pro-fibrogenic factor produced by PTE. Although hypoxia stimulated TGF-beta production (2- to 3-fold), neutralizing anti-TGF-beta1 antibody did not abolish the hypoxia-induced changes in gelatinase activity, TIMP-1, collagen IV or collagen I mRNA expression, implying that TGF-beta1 is not the mediator. Furthermore, exogenous TGF-beta1 (0 to 10 ng/ml) did not mimic hypoxia, as it stimulated MMP-2 activity and increased the expression of collagen IV, collagen I and TIMP-1 mRNA. The data suggest that hypoxia may be an important pro-fibrogenic stimulus independent of TGF-beta1.

Citing Articles

The AKI-to-CKD Transition: The Role of Uremic Toxins.

Andre C, Bodeau S, Kamel S, Bennis Y, Caillard P Int J Mol Sci. 2023; 24(22).

PMID: 38003343 PMC: 10671582. DOI: 10.3390/ijms242216152.


Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming.

Rahbar Saadat Y, Hosseiniyan Khatibi S, Sani A, Zununi Vahed S, Ardalan M Inflammopharmacology. 2023; 31(4):1657-1669.

PMID: 37131045 DOI: 10.1007/s10787-023-01232-x.


Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy.

Mihaljevic V, Zjalic M, Kizivat T, Kolaric T, Smolic M, Rodak E Biomedicines. 2022; 10(11).

PMID: 36428551 PMC: 9687879. DOI: 10.3390/biomedicines10112983.


Characterization of the Impacts of Living at High Altitude in Taif: Oxidative Stress Biomarker Alterations and Immunohistochemical Changes.

Soliman M, Aldhahrani A, Althobaiti F, Ahmed M, Sayed S, Alotaibi S Curr Issues Mol Biol. 2022; 44(4):1610-1625.

PMID: 35723368 PMC: 9164078. DOI: 10.3390/cimb44040110.


Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy.

Nincevic V, Zjalic M, Kolaric T, Smolic M, Kizivat T, Kuna L Curr Issues Mol Biol. 2022; 44(3):1087-1114.

PMID: 35723295 PMC: 8947663. DOI: 10.3390/cimb44030072.